IgA defects in CVID lead to bacterial translocation, increased serum γ-interferon, and BAFF
- PMID: 41608052
- PMCID: PMC12829748
- DOI: 10.70962/jhi.20250080
IgA defects in CVID lead to bacterial translocation, increased serum γ-interferon, and BAFF
Abstract
Common variable immunodeficiency (CVID) is a primary antibody defect that leads to frequent infections, but inflammatory complications appear in 30-50%, leading to increased morbidity and mortality. We have previously shown that circulating bacterial 16S ribosomal DNA (rDNA), originating from gut commensals, is significantly increased in the serum of patients with CVID with inflammatory conditions (P = 0.0007). Here we examined the relationships between serum 16S ribosomal DNA (rDNA), isotype-switched memory (SM) B cells, serum IgA, IgA+ SM B cells, serum IFN-γ, and serum B cell-activating factor (BAFF). We found a significant inverse correlation between serum 16S ribosomal DNA (rDNA) concentrations and the numbers of isotype SM B cells, IgA+ SM B cells, and serum IgA levels in our large cohort, suggesting that loss of IgA in the mucosal barrier permits bacterial transcytosis. Loss of SM B cells and lower serum IgA concentrations were both associated with increased serum IFN-γ, as well as increased CXCL9 and serum BAFF concentrations. Serum BAFF was also significantly associated with IFN-γ levels and inversely correlated with baseline serum IgA. We conclude that loss of IgA, accompanied by mucosal defects in CVID, may permit bacterial transcytosis, resulting in excessive IFN-γ and BAFF production, both of which promote autoimmune and inflammatory complications in this immune defect.
© 2026 Ho et al.
Conflict of interest statement
Disclosures: H. Ho reported personal fees from Sanofi outside the submitted work. E. Meffre reported personal fees from Genentech, Boehringer Ingelheim, Anovo, and Merck outside the submitted work. No other disclosures were reported.
Figures
References
-
- Bonilla, F.A., Barlan I., Chapel H., Costa-Carvalho B.T., Cunningham-Rundles C., de la Morena M.T., Espinosa-Rosales F.J., Hammarström L., Nonoyama S., Quinti I., et al. 2016. International consensus document (ICON): Common variable immunodeficiency disorders. J. Allergy Clin. Immunol. Pract. 4:38–59. 10.1016/j.jaip.2015.07.025 - DOI - PMC - PubMed
-
- Seidel, M.G., Kindle G., Gathmann B., Quinti I., Buckland M., van Montfrans J., Scheible R., Rusch S., Gasteiger L.M., Grimbacher B., et al. 2019. The European society for immunodeficiencies (ESID) registry working definitions for the clinical diagnosis of inborn errors of immunity. J. Allergy Clin. Immunol. Pract. 7:1763–1770. 10.1016/j.jaip.2019.02.004 - DOI - PubMed
-
- Tangye, S.G., Al-Herz W., Bousfiha A., Cunningham-Rundles C., Franco J.L., Holland S.M., Klein C., Morio T., Oksenhendler E., Picard C., et al. 2022. Human inborn errors of immunity: 2022 Update on the classification from the international union of immunological societies expert committee. J. Clin. Immunol. 42:1473–1507. 10.1007/s10875-022-01289-3 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous